Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02550925 · ClinicalTrials.gov registry record · NA
Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors
A NA study, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- NA
- Development phase
- 139
- Enrollment target
NCT02550925 is a NA study that has completed, run by University of Colorado, Boulder. The registered enrollment target is 139 participants.
The verdict
NCT02550925, a NA study, has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- NA
- Development phase
- 139 participants
- Enrollment target
Study Summary
This randomized clinical trial compares group acceptance and commitment therapy (ACT) to usual care for cancer survivors experiencing anxiety following the end of cancer treatment.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Acceptance and Commitment Therapy (ACT) Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2015-09 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02550925
The ClinicalTrials.gov registry entry for NCT02550925 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT02550925 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02550925 about?
NCT02550925 is a clinical study titled "Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors". This randomized clinical trial compares group acceptance and commitment therapy (ACT) to usual care for cancer survivors experiencing anxiety following the end of cancer treatment.
What is the current status of trial NCT02550925?
This trial is currently completed. It is a NA study. The enrollment target is 139 participants. The study started on 2015-09. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT02550925?
The interventions under investigation include: Usual Care (BEHAVIORAL), Acceptance and Commitment Therapy (ACT) Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT02550925?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.